DONALDSON Co INC DCI
The biggest changes in the 10-K filed Sep 25, 2026, in management's words
10-K, Item 7This fiscal year against the last, and the sentences in the MD&A where management explains each change. Tickdelta picks sentences that name the line, a direction and a cause. It does not write explanations of its own.
Net income
Big change, FY to Jul 31, 2026 vs Jul 31, 2025
“Other income, net for the year ended July 31, 2026 was $21.9 million, compared with $21.0 million for the year ended July 31, 2025, an increase of $0.9 million, or 4.3%, driven primarily by higher income from equity investments and joint ventures, partially offset by higher pension expense.”
Read it in the 10-K
Operating margin
Big change, FY to Jul 31, 2026 vs Jul 31, 2025
“The increase in selling, general and administrative expenses as a percentage of net sales was primarily due to an $8.9 million increase in amortization expense from the Facet acquisition, as well as a $4.0 million benefit from the reduction of the Purilogics’ contingent consideration liability in the prior fiscal year that did not repeat in the current fiscal year and the effects of normal inflation, partially offset by ongoing disciplined expense management.”
Read it in the 10-K
“The decrease in research and development expenses as a percentage of net sales was primarily driven by focused project prioritization.”
Read it in the 10-K
Cash from operations
Big change, FY to Jul 31, 2026 vs Jul 31, 2025
“The increase in cash provided by operating activities was primarily driven by higher earnings and improved working capital management, including lower cash usage related to inventory, partially offset by an increase in accounts receivable driven by strong sales growth in the fourth quarter.”
Read it in the 10-K
Revenue
Change, FY to Jul 31, 2026 vs Jul 31, 2025
“Net sales for the year ended July 31, 2026 increased $194.7 million, or 5.3% from fiscal 2025, reflecting higher sales in the Mobile Solutions segment of $128.7 million, or 5.6%, the Life Sciences segment of $37.7 million, or 12.8%, and the Industrial Solutions segment of $28.3 million, or 2.6%.”
Read it in the 10-K
“Foreign currency translation increased net sales by $67.6 million, reflecting increases in the Mobile Solutions, Industrial Solutions and Life Sciences segments of $42.0 million, $15.5 million and $10.1 million, respectively.”
Read it in the 10-K
Gross margin
Change, FY to Jul 31, 2026 vs Jul 31, 2025
“The decrease in gross margin as a percentage of net sales was driven primarily by operational inefficiencies related to shifting Power Generation equipment production to a new point of manufacturing to support customer-specific requirements in Industrial Solutions and costs associated with footprint optimization efforts, partially offset by favorable mix, favorable net pricing and volume leverage.”
Read it in the 10-K
What management said, year by year
The cause given in each 10-K, 2 fiscal years, newest first · MD&A (Item 7)
Each bar is how the line changed that year (from the same 10-K's XBRL). Under it, the sentence in that year's MD&A that names the line, a direction and a cause, word for word. A year with no sentence says so.
Revenue
2 of 2 years explained-
FY 2026 +5.3%
“Net sales for the year ended July 31, 2026 increased $194.7 million, or 5.3% from fiscal 2025, reflecting higher sales in the Mobile Solutions segment of $128.7 million, or 5.6%, the Life Sciences segment of $37.7 million, or 12.8%, and the Industrial Solutions segment of $28.3 million, or 2.6%.”
Read it in the FY 2026 10-K“Foreign currency translation increased net sales by $67.6 million, reflecting increases in the Mobile Solutions, Industrial Solutions and Life Sciences segments of $42.0 million, $15.5 million and $10.1 million, respectively.”
Read it in the FY 2026 10-K -
FY 2025 +2.9%
“Net sales for the year ended July 31, 2025 increased $104.6 million, or 2.9% from fiscal 2024, reflecting higher sales in the Mobile Solutions segment of $40.2 million, or 1.8%, the Industrial Solutions segment of $37.9 million, or 3.6%, and the Life Sciences segment of $26.5 million, or 9.8%.”
Read it in the FY 2025 10-K“Foreign currency translation increased net sales by $8.3 million, reflecting increases in the Industrial Solutions and Life Sciences segments of $4.7 million and $5.2 million, respectively, and a decrease in the Mobile Solutions segment of $1.6 million.”
Read it in the FY 2025 10-K
Gross margin
2 of 2 years explained-
FY 2026 -0.2 pts
“The decrease in gross margin as a percentage of net sales was driven primarily by operational inefficiencies related to shifting Power Generation equipment production to a new point of manufacturing to support customer-specific requirements in Industrial Solutions and costs associated with footprint optimization efforts, partially offset by favorable mix, favorable net pricing and volume leverage.”
Read it in the FY 2026 10-K -
FY 2025 -0.7 pts
“The decrease in gross margin as a percentage of net sales was driven primarily by higher manufacturing costs associated with footprint optimization initiatives and tariff related inflation on the Company’s LIFO inventory valuation.”
Read it in the FY 2025 10-K
Operating margin
2 of 2 years explained-
FY 2026 +2.0 pts
“The increase in selling, general and administrative expenses as a percentage of net sales was primarily due to an $8.9 million increase in amortization expense from the Facet acquisition, as well as a $4.0 million benefit from the reduction of the Purilogics’ contingent consideration liability in the prior fiscal year that did not repeat in the current fiscal year and the effects of normal inflation, partially offset by ongoing disciplined expense management.”
Read it in the FY 2026 10-K“The decrease in research and development expenses as a percentage of net sales was primarily driven by focused project prioritization.”
Read it in the FY 2026 10-K -
FY 2025 -1.7 pts
“The decrease in selling, general and administrative expenses as a percentage of net sales was primarily due to ongoing disciplined expense management and a $4.0 million benefit from the reduction of the Purilogics’ contingent consideration liability, which represents the fair value based on the probability of achieving certain milestones, partially offset by restructuring, business development and other non-recurring expenses.”
Read it in the FY 2025 10-K“The decrease in research and development expenses as a percentage of net sales was primarily driven by focused project prioritization.”
Read it in the FY 2025 10-K
Net income
2 of 2 years explained-
FY 2026 +23.7%
“Other income, net for the year ended July 31, 2026 was $21.9 million, compared with $21.0 million for the year ended July 31, 2025, an increase of $0.9 million, or 4.3%, driven primarily by higher income from equity investments and joint ventures, partially offset by higher pension expense.”
Read it in the FY 2026 10-K -
FY 2025 -11.4%
“Other income, net for the year ended July 31, 2025 was $21.0 million, compared with $12.6 million for the year ended July 31, 2024, an increase of $8.4 million, or 66.8%, driven primarily by lower pension related expenses in the current year.”
Read it in the FY 2025 10-K“The higher effective tax rate was primarily due to the fiscal 2025 third quarter loss on impairment of intangible assets, as the discrete tax benefit on the loss on impairment of intangible assets was reduced by an increase in valuation allowance.”
Read it in the FY 2025 10-K
Cash from operations
2 of 2 years explained-
FY 2026 +17.9%
“The increase in cash provided by operating activities was primarily driven by higher earnings and improved working capital management, including lower cash usage related to inventory, partially offset by an increase in accounts receivable driven by strong sales growth in the fourth quarter.”
Read it in the FY 2026 10-K -
FY 2025 -15.0%
“The decrease in cash provided by operating activities was primarily driven by higher working capital requirements and the timing of income tax related payments.”
Read it in the FY 2025 10-K
Changes are computed from the XBRL figures in the same 10-K. Hover a number to see the line item. Open the 10-K
Sources
The Management's Discussion and Analysis (Item 7) of the latest 10-K, quoted word for word; the changes are computed from the same 10-K's XBRL.
Also
Financials: the numbers year by year.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/DCI/export.csv") into a cell.